Current Evidence Base of FDG-PET/CT Imaging in the Clinical Management of Malignant Pleural Mesothelioma: Emerging Significance of Image Segmentation and Global Disease Assessment
dc.contributor.author | Basu, Sandip | |
dc.contributor.author | Saboury, B. | |
dc.contributor.author | Torigian, D. A. | |
dc.contributor.author | Alavi, A. | |
dc.date.accessioned | 2012-04-13T05:27:59Z | |
dc.date.available | 2012-04-13T05:27:59Z | |
dc.date.issued | 2011 | |
dc.format.extent | 6400 bytes | |
dc.format.mimetype | text/html | |
dc.identifier.source | Molecular Imaging and Biology, 2011. Vol. 13 (5): pp. 801-811 | en |
dc.identifier.uri | http://hdl.handle.net/123456789/6131 | |
dc.language.iso | en | en |
dc.subject | PET | en |
dc.subject | PET/CT | en |
dc.subject | Mesothelioma | en |
dc.subject | FDG | en |
dc.subject | Pleural mesothelioma | en |
dc.subject | Malignant pleural mesothelioma | en |
dc.title | Current Evidence Base of FDG-PET/CT Imaging in the Clinical Management of Malignant Pleural Mesothelioma: Emerging Significance of Image Segmentation and Global Disease Assessment | en |
dc.type | Article | en |